Frontiers in Genetics (Jan 2023)
GWAS of depression in 4,520 individuals from the Russian population highlights the role of MAGI2 (S-SCAM) in the gut-brain axis
- Daria Pinakhina,
- Danat Yermakovich,
- Ekaterina Vergasova,
- Evgeny Kasyanov,
- Grigory Rukavishnikov,
- Valeriia Rezapova,
- Valeriia Rezapova,
- Valeriia Rezapova,
- Nikita Kolosov,
- Nikita Kolosov,
- Nikita Kolosov,
- Alexey Sergushichev,
- Iaroslav Popov,
- Elena Kovalenko,
- Anna Ilinskaya,
- Anna Kim,
- Nikolay Plotnikov,
- Valery Ilinsky,
- Valery Ilinsky,
- Nikholay Neznanov,
- Nikholay Neznanov,
- Galina Mazo,
- Alexander Kibitov,
- Alexander Rakitko,
- Alexander Rakitko,
- Mykyta Artomov,
- Mykyta Artomov,
- Mykyta Artomov,
- Mykyta Artomov
Affiliations
- Daria Pinakhina
- ITMO University, Saint-Petersburg, Russia
- Danat Yermakovich
- Genotek Ltd., Moscow, Russia
- Ekaterina Vergasova
- Genotek Ltd., Moscow, Russia
- Evgeny Kasyanov
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Grigory Rukavishnikov
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Valeriia Rezapova
- ITMO University, Saint-Petersburg, Russia
- Valeriia Rezapova
- Almazov National Medical Research Center, Saint-Petersburg, Russia
- Valeriia Rezapova
- Broad Institute, Cambridge, MA, United States
- Nikita Kolosov
- ITMO University, Saint-Petersburg, Russia
- Nikita Kolosov
- Almazov National Medical Research Center, Saint-Petersburg, Russia
- Nikita Kolosov
- Broad Institute, Cambridge, MA, United States
- Alexey Sergushichev
- ITMO University, Saint-Petersburg, Russia
- Iaroslav Popov
- Genotek Ltd., Moscow, Russia
- Elena Kovalenko
- Genotek Ltd., Moscow, Russia
- Anna Ilinskaya
- Genotek Ltd., Moscow, Russia
- Anna Kim
- Genotek Ltd., Moscow, Russia
- Nikolay Plotnikov
- Genotek Ltd., Moscow, Russia
- Valery Ilinsky
- Genotek Ltd., Moscow, Russia
- Valery Ilinsky
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Nikholay Neznanov
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Nikholay Neznanov
- First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia
- Galina Mazo
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Alexander Kibitov
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Alexander Rakitko
- Genotek Ltd., Moscow, Russia
- Alexander Rakitko
- V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia
- Mykyta Artomov
- Broad Institute, Cambridge, MA, United States
- Mykyta Artomov
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States
- Mykyta Artomov
- The Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, United States
- Mykyta Artomov
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, United States
- DOI
- https://doi.org/10.3389/fgene.2022.972196
- Journal volume & issue
-
Vol. 13
Abstract
We present the results of the depression Genome-wide association studies study performed on a cohort of Russian-descent individuals, which identified a novel association at chromosome 7q21 locus. Gene prioritization analysis based on already known depression risk genes indicated MAGI2 (S-SCAM) as the most probable gene from the locus and potential susceptibility gene for the disease. Brain and gut expression patterns were the main features highlighting functional relatedness of MAGI2 to the previously known depression risk genes. Local genetic covariance analysis, analysis of gene expression, provided initial suggestive evidence of hospital anxiety and depression scale and diagnostic and statistical manual of mental disorders scales having a different relationship with gut-brain axis disturbance. It should be noted, that while several independent methods successfully in silico validate the role of MAGI2, we were unable to replicate genetic association for the leading variant in the MAGI2 locus, therefore the role of rs521851 in depression should be interpreted with caution.
Keywords